A meta-analysis of 13 studies showed increased visfatin concentrations in participants with overt obesity, T2DM, metabolic syndrome, and cardiovascular diseases, which were positively associated with insulin resistance22. This evidence concerns the gene NAMPT and type 2 diabetes mellitus.